Skip to main content
OpenTrials

Clinical trial condition

Paraproteinemias

Explore clinical trials studying Paraproteinemias. Study availability and eligibility vary by location and protocol.

3,006 public trials 571 recruiting studies
Refine in advanced search Browse all conditions

Paraproteinemias trial results

Completed

Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer

NCT00516503

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +33 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • Mayo Clinic - Jacksonville Jacksonville, Florida, United States
  • Rush-Copley Cancer Care Center Aurora, Illinois, United States
  • St. Joseph Medical Center Bloomington, Illinois, United States
View all 165 locations
View Trial Details
Completed

Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma

NCT00531284

Conditions
Adnexal Diseases, Blood Protein Disorders, Bronchial Neoplasms, +47 more
Locations
  • Pinnacle Oncology Scottsdale, Arizona, United States
  • Tower Cancer Research Foundation Beverly Hills, California, United States
  • Northwestern University Chicago, Illinois, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
View Trial Details
Completed

Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function

NCT01393964

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Winship Cancer Institute, Emory University Atlanta, Georgia, United States
  • Investigative Clinical Research Of Indiana, Llc Indianapolis, Indiana, United States
  • University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States
  • University Of Maryland Baltimore, Maryland, United States
View Trial Details
Completed

A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms

NCT02842229

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +28 more
Locations
  • Hospital Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Durán I Reynals L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Parc Taulí Sabadell, Barcelona, Spain
  • C.H. Universitario A Coruña A Coruña, La Coruña, Spain
View all 15 locations
View Trial Details
Completed

Fludarabine and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Chronic Lymphocytic Leukemia or Waldenstrom's Macroglobulinemia

NCT00281983

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +22 more
Locations
  • Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada
  • Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany
  • Universitaetsklinikum Essen Essen, Germany
  • Universitaetsklinikum Goettingen Göttingen, Germany
View all 13 locations
View Trial Details
Completed

Fenretinide in Treating Patients With Refractory or Relapsed Hematologic Cancer

NCT00104923

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Blood Protein Disorders, +58 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States
  • M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States
  • Joe Arrington Cancer Research and Treatment Center Lubbock, Texas, United States
View Trial Details

Related conditions